Cargando…

Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease

Few studies investigated the respiratory outcomes of metformin use in patients with coexistent type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD). We want to compare the long-term respiratory endpoints of metformin use and nonuse in patients with T2DM and COPD. This ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Fu-Shun, Wei, James Cheng-Chung, Yang, Yu-Cih, Hsu, Chih-Cheng, Hwu, Chii-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314747/ https://www.ncbi.nlm.nih.gov/pubmed/32581289 http://dx.doi.org/10.1038/s41598-020-67338-2

Ejemplares similares

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design
por: Yen, Fu-Shun, et al.
Publicado: (2018)

Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Parental Income Level and Risk of Developing Type 2 Diabetes in Youth
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Diabetes, hypertension, and cardiovascular disease development
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2019)

The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes
por: Yeh, Yun Kai, et al.
Publicado: (2023)

Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?
por: Yen, Fu‐Shun, et al.
Publicado: (2023)

Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
por: Ho, Te-Wei, et al.
Publicado: (2019)

Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan
por: Wang, Jun-Sing, et al.
Publicado: (2022)

Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study
por: Shen, Te-Chun, et al.
Publicado: (2014)

Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis–Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study
por: Yeh, Jun-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_26pnr99vscjq83vhqcv872vkqn